bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: S A J J M A M F J
2016: D N O S

 
  Other news for:
Cholesterol
 Resources from HONselect
Statins Help Healthy People Lower Their 'Bad' Cholesterol
Study found taking them lowered risk of heart disease, death in those with high LDL levels

By Robert Preidt

THURSDAY, Sept. 7, 2017 (HealthDay News) -- Cholesterol-lowering statins reduce the risk of heart disease and death in otherwise healthy people who have very high levels of "bad" LDL cholesterol, a long-term study finds.

For 20 years, more than 5,500 men in Scotland who did not have heart disease but who had high levels of LDL took 40 milligrams of pravastatin, a relatively weak type of statin, daily. Doing so reduced their overall risk of death by 18 percent, the risk of death from heart disease by 28 percent, and the risk of death from other cardiovascular diseases by 25 percent.

"For the first time, we show that statins reduce the risk of death in this specific group of people who appear largely healthy, except for very high LDL levels," said study senior author Dr. Kausik Ray, a professor in the School of Public Health at Imperial College London.

The findings challenge taking a "watch-and-wait" approach in younger patients with elevated LDL levels, according to the researchers. They said even people with slightly elevated cholesterol have a higher long-term risk of heart disease.

"This is the strongest evidence yet that statins reduce the risk of heart disease and death in men with high LDL," Ray said in a college news release.

"Our study lends support to LDL's status as a major driver of heart disease risk, and suggests that even modest LDL reductions might offer significant mortality benefits in the long term," Ray concluded.

The study was published Sept. 6 in the journal Circulation.

More information

The U.S. Food and Drug Administration has more on cholesterol and statins.

SOURCE: Imperial College London, news release, Sept. 6, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=726299

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Cholesterol
Risk
Heart
Heart Diseases
Death
Men
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact